Condition: Non-ischemic Dilated Cardiomyopathy · Sponsor: Joshua M Hare
The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called human allogeneic mesenchymal stem cell therapy.
This description comes directly from the study's public registry record.
Shelly L Sayre, MPH · 713-500-9529 · Shelly.L.Sayre@uth.tmc.edu
Lina Caceres · 305-243-5399 · lvc25@med.miami.edu
Always discuss trial participation with your own doctor first.
| Stanford University | Stanford, California, United States | Recruiting |
| University of Miami Miller School of Medicine | Miami, Florida, United States | Recruiting |
| University of Louisville | Louisville, Kentucky, United States | Recruiting |
| Texas Heart Institute | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04476901